4,269
Views
124
CrossRef citations to date
0
Altmetric
Article Addendum

Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics

, , &
Pages 233-238 | Received 26 Nov 2013, Accepted 20 Jan 2014, Published online: 23 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Srinivas Kamath, Andrea M. Stringer, Clive A. Prestidge & Paul Joyce. (2023) Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opinion on Drug Delivery 20:10, pages 1315-1331.
Read now
Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, Nejra Selak, Nejra Osmančević, Esma Karahmet Farhat & Farooq Sher. (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metabolism Reviews 55:1-2, pages 126-139.
Read now
Gabriel Tao, Junqing Huang, Bhagavatula Moorthy, Cathryn Wang, Ming Hu, Song Gao & Romi Ghose. (2020) Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1109-1124.
Read now
Aleksandra Tarasiuk & Jakub Fichna. (2019) Gut microbiota: what is its place in pharmacology?. Expert Review of Clinical Pharmacology 12:10, pages 921-930.
Read now
Diego Currò. (2018) The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Review of Clinical Pharmacology 11:2, pages 171-183.
Read now
Barbara E. Ostrov & Daniel Amsterdam. (2017) Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases. Immunological Investigations 46:8, pages 769-792.
Read now

Articles from other publishers (117)

Aditya S. Malwe & Vineet K. Sharma. (2023) Application of artificial intelligence approaches to predict the metabolism of xenobiotic molecules by human gut microbiome. Frontiers in Microbiology 14.
Crossref
Yong Cheol Shin, Nam Than, Soyoun Min, Woojung Shin & Hyun Jung Kim. (2023) Modelling host–microbiome interactions in organ-on-a-chip platforms. Nature Reviews Bioengineering.
Crossref
Qing Zhao, Yao Chen, Weihua Huang, Honghao Zhou & Wei Zhang. (2023) Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduction and Targeted Therapy 8:1.
Crossref
Jingwei Cai, Alexis Auster, Sungjoon Cho & Zijuan Lai. (2023) Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage. Journal of Advanced Research.
Crossref
Madeleine Ball & Billy Boyle. (2023) Breath Can Deepen Our Understanding of the Microbiome. Genetic Engineering & Biotechnology News 43:6, pages 24-26.
Crossref
Sara Mousa, Muhammad Sarfraz & Walaa K. Mousa. (2023) The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine. Metabolites 13:5, pages 674.
Crossref
Alya Heirali, Shirin Moossavi, Marie Claire Arrieta & Bryan Coburn. (2023) Principles and Terminology for Host–Microbiome–Drug Interactions. Open Forum Infectious Diseases 10:5.
Crossref
Carmen Purdel, Anca Ungurianu, Ines Adam-Dima & Denisa Margină. (2023) Exploring the potential impact of probiotic use on drug metabolism and efficacy. Biomedicine & Pharmacotherapy 161, pages 114468.
Crossref
Zeyu Xu, Mei Dong, Shaoping Yin, Jie Dong, Ming Zhang, Rong Tian, Wen Min, Li Zeng, Hongzhi Qiao & Jun Chen. (2023) Why traditional herbal medicine promotes wound healing: Research from immune response, wound microbiome to controlled delivery. Advanced Drug Delivery Reviews 195, pages 114764.
Crossref
Raaj S. Mehta, Jared R. Mayers, Yancong Zhang, Amrisha Bhosle, Nathaniel R. Glasser, Long H. Nguyen, Wenjie Ma, Sena Bae, Tobyn Branck, Kijun Song, Luke Sebastian, Julian Avila Pacheco, Hyuk-Soo Seo, Clary Clish, Sirano Dhe-Paganon, Ashwin N. Ananthakrishnan, Eric A. Franzosa, Emily P. Balskus, Andrew T. Chan & Curtis Huttenhower. (2023) Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. Nature Medicine 29:3, pages 700-709.
Crossref
Cassandra Mah, Thisun Jayawardana, Gary Leong, Sabrina Koentgen, Daniel Lemberg, Susan J. Connor, Theodore Rokkas, Michael C. Grimm, Steven T. Leach & Georgina L. Hold. (2023) Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review. Pathogens 12:2, pages 262.
Crossref
Alessia Favaron, Laura E. McCoubrey, Moe Elbadawi, Abdul W. Basit & Mine Orlu. 2023. Pharmaceutical Formulations for Older Patients. Pharmaceutical Formulations for Older Patients 191 230 .
Siqi Chen, Tiancheng Li, Luna Yang, Fei Zhai, Xiwei Jiang, Rongwu Xiang & Guixia Ling. (2022) Artificial intelligence-driven prediction of multiple drug interactions. Briefings in Bioinformatics 23:6.
Crossref
Chengyao Wang, Andrea Cancino, Jasmine Baste, Daniel Marten, Advait Anil Joshi, Amreen Nasreen & Abhinav Bhushan. (2022) Causative Role of Anoxic Environment in Bacterial Regulation of Human Intestinal Function. Cellular and Molecular Bioengineering 15:5, pages 493-504.
Crossref
M. Denise DearingSara B. Weinstein. (2022) Metabolic Enabling and Detoxification by Mammalian Gut Microbes. Annual Review of Microbiology 76:1, pages 579-596.
Crossref
Skender Topi, Lucrezia Bottalico, Ioannis Alexandros Charitos, Marica Colella, Marina Di Domenico, Raffaele Palmirotta & Luigi Santacroce. (2022) Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe?. Pathophysiology 29:3, pages 507-536.
Crossref
Valeria M. Juarez, Alyssa N. Montalbine & Ankur Singh. (2022) Microbiome as an immune regulator in health, disease, and therapeutics. Advanced Drug Delivery Reviews 188, pages 114400.
Crossref
Sabrina Sprotte, Torben S. Rasmussen, Gyu-Sung Cho, Erik Brinks, René Lametsch, Horst Neve, Finn K. Vogensen, Dennis S. Nielsen & Charles M. A. P. Franz. (2022) Morphological and Genetic Characterization of Eggerthella lenta Bacteriophage PMBT5. Viruses 14:8, pages 1598.
Crossref
Lacey R. Lopez, Ju-Hyun Ahn, Tomaz Alves & Janelle C. Arthur. (2022) Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Aysenur Gunaydin AkyildizGiuseppe Biondi-ZoccaiDaniela De Biase. (2022) Impact of the Gastrointestinal Tract Microbiota on Cardiovascular Health and Pathophysiology. Journal of Cardiovascular Pharmacology 80:1, pages 13-30.
Crossref
Zehra Esra Ilhan & Melissa M. Herbst-Kralovetz. 2022. Metabolism of Nutrients by Gut Microbiota. Metabolism of Nutrients by Gut Microbiota 120 149 .
Jing Guo, Ying Xu, Li-jie Chen, Song-xia Zhang, Yu-ligh Liou, Xiao-ping Chen, Zhi-rong Tan, Hong-hao Zhou, Wei Zhang & Yao Chen. (2022) Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug. Journal of Advanced Research 39, pages 319-332.
Crossref
Xiangyun Li, Enjun Xu, Cuixiao Shi, Guanhua Qiao, Shuyi Chen, Yuanhong Xu, Yajing Liu & Xundi Bao. (2022) Identification and Antibiotic Susceptibility of Eggerthella lenta in Bloodstream Infections . Polish Journal of Microbiology 71:2, pages 257-261.
Crossref
Byron J. Smith, Xiangpeng Li, Zhou Jason Shi, Adam Abate & Katherine S. Pollard. (2022) Scalable Microbial Strain Inference in Metagenomic Data Using StrainFacts. Frontiers in Bioinformatics 2.
Crossref
Abdelaziz El Houari, Florine Ecale, Anne Mercier, Stéphanie Crapart, Jérôme Laparre, Baptiste Soulard, Manilduth Ramnath, Jean-Marc Berjeaud, Marie-Hélène Rodier & Alexandre Crépin. (2022) Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics. Frontiers in Microbiology 13.
Crossref
Atheer Awad, Christine M. Madla, Laura E. McCoubrey, Fabiana Ferraro, Francesca K.H. Gavins, Asma Buanz, Simon Gaisford, Mine Orlu, Florence Siepmann, Juergen Siepmann & Abdul W. Basit. (2022) Clinical translation of advanced colonic drug delivery technologies. Advanced Drug Delivery Reviews 181, pages 114076.
Crossref
Yating Wan & Tao Zuo. (2022) Interplays between drugs and the gut microbiome. Gastroenterology Report 10.
Crossref
Daniel A. Schupack, Ruben A. T. Mars, Dayne H. Voelker, Jithma P. Abeykoon & Purna C. Kashyap. (2021) The promise of the gut microbiome as part of individualized treatment strategies. Nature Reviews Gastroenterology & Hepatology 19:1, pages 7-25.
Crossref
Jiajia Zhou, Jian Ouyang, Zihao Gao, Haipeng Qin, Wu Jun & Tieliu Shi. (2022) MagMD: Database summarizing the metabolic action of gut microbiota to drugs. Computational and Structural Biotechnology Journal 20, pages 6427-6430.
Crossref
Laura E. McCoubrey, Simon Gaisford, Mine Orlu & Abdul W. Basit. (2022) Predicting drug-microbiome interactions with machine learning. Biotechnology Advances 54, pages 107797.
Crossref
Tanshi Mehrotra & Subir Kumar Maulik. 2022. Human Microbiome in Health and Disease - Part A. Human Microbiome in Health and Disease - Part A 207 228 .
Aqsa Shahid, Sumreen Hayat, Samman Munir, Usman Ali Ashfaq, Abdul Arif Khan, Muhammad Bilal, Irfan Shaukat & Mohsin Khurshid. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes 375 397 .
Huijue Jia. 2022. Investigating Human Diseases with the Microbiome. Investigating Human Diseases with the Microbiome 157 187 .
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh & Rajesh Kumar Singh. 2022. Xenobiotics in Chemical Carcinogenesis. Xenobiotics in Chemical Carcinogenesis 217 243 .
Arthur J. AtkinsonJr.Jr.. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology 43 59 .
Susannah Selber-Hnatiw. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota 46 68 .
C.J. García, R. García-Villalba, D.A. Moreno & F.A. Tomás-Barberán. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota 124 148 .
Tarun Kumar & Nar Singh Chauhan. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota 234 245 .
Yusha Luo & Tingting Zhou. (2021) Connecting the dots: Targeting the microbiome in drug toxicity. Medicinal Research Reviews 42:1, pages 83-111.
Crossref
Joanna Nycz & Alicja Zajdel. (2021) Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 762-772.
Crossref
Zidong Donna Fu, Felcy Pavithra Selwyn, Julia Yue Cui & Curtis D. Klaassen. (2021) RNA-Seq unveiled section-specific host response to lack of gut microbiota in mouse intestine. Toxicology and Applied Pharmacology 433, pages 115775.
Crossref
Laura E. McCoubrey, Stavriani Thomaidou, Moe Elbadawi, Simon Gaisford, Mine Orlu & Abdul W. Basit. (2021) Machine Learning Predicts Drug Metabolism and Bioaccumulation by Intestinal Microbiota. Pharmaceutics 13:12, pages 2001.
Crossref
Lavinia Curini & Amedeo Amedei. (2021) Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance. Biomedicines 9:10, pages 1338.
Crossref
Noora Alhajri, Rubiya Khursheed, Mohammad Taher Ali, Tareq Abu Izneid, Oumaima Al-Kabbani, Mahdia B. Al-Haidar, Fatima Al-Hemeiri, Mohamed Alhashmi & Faheem Hyder Pottoo. (2021) Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota. Microorganisms 9:10, pages 2013.
Crossref
Martina Klünemann, Sergej Andrejev, Sonja Blasche, Andre Mateus, Prasad Phapale, Saravanan Devendran, Johanna Vappiani, Bernd Simon, Timothy A. Scott, Eleni Kafkia, Dimitrios Konstantinidis, Katharina Zirngibl, Eleonora Mastrorilli, Manuel Banzhaf, Marie-Therese Mackmull, Felix Hövelmann, Leo Nesme, Ana Rita Brochado, Lisa Maier, Thomas Bock, Vinita Periwal, Manjeet Kumar, Yongkyu Kim, Melanie Tramontano, Carsten Schultz, Martin Beck, Janosch Hennig, Michael Zimmermann, Daniel C. Sévin, Filipe Cabreiro, Mikhail M. Savitski, Peer Bork, Athanasios Typas & Kiran R. Patil. (2021) Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 597:7877, pages 533-538.
Crossref
Rodney R. Dietert. (2021) Microbiome First Medicine in Health and Safety. Biomedicines 9:9, pages 1099.
Crossref
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin & Zhonggao Gao. (2021) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 11:7, pages 1789-1812.
Crossref
Mara Lucchetti, Mathilda Kaminska, Aina Kehinde Oluwasegun, Alexander S. Mosig & Paul Wilmes. (2021) Emulating the gut–liver axis: Dissecting the microbiome's effect on drug metabolism using multiorgan-on-chip models. Current Opinion in Endocrine and Metabolic Research 18, pages 94-101.
Crossref
Nadji Hannachi & Laurence Camoin-Jau. (2021) Drug Response Diversity: A Hidden Bacterium?. Journal of Personalized Medicine 11:5, pages 345.
Crossref
Thomas C.A. Hitch, Afrizal Afrizal, Thomas Riedel, Antonios Kioukis, Dirk Haller, Ilias Lagkouvardos, Jörg Overmann & Thomas Clavel. (2021) Recent advances in culture-based gut microbiome research. International Journal of Medical Microbiology 311:3, pages 151485.
Crossref
Raaj S. Mehta, Bharati D. Kochar, Korey Kennelty, Michael E. Ernst & Andrew T. Chan. (2021) Emerging approaches to polypharmacy among older adults. Nature Aging 1:4, pages 347-356.
Crossref
R. Fitger. (2021) Mikrobiom und Gehirn. Der Merkurstab 74:2, pages 130-148.
Crossref
Benito Soto-Blanco. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 410 414 .
Yvonne S. Lin, Kenneth E. Thummel, Brice D. Thompson, Rheem A. Totah & Christi W. Cho. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism 481 550 .
Kavita Vijay CHAUDHARİ, Rakhi BİSWAS, Meghna C, Sujatha SİSTLA, Kadambari DHARANİPRAGADA, Balasubramanian KRİSHNAN & Akhilesh R. (2020) Isolation of Eggerthella lenta from A Cutaneous Abscess Formed at Post-trauma Suture Site. Journal of Microbiology and Infectious Diseases, pages 230-233.
Crossref
Agne Sveistyte, Teresa Gibbins, Kimberly J. Tyrrell, Carson J. Miller, Matt H. Foley, Andrew E. Plymale, Aaron T. Wright & Kristoffer R. Brandvold. (2020) Simple Analysis of Primary and Secondary Bile Salt Hydrolysis in Mouse and Human Gut Microbiome Samples by Using Fluorogenic Substrates. ChemBioChem 21:24, pages 3539-3543.
Crossref
Ryan K. Cheu, Andrew T. Gustin, Christina Lee, Luca Schifanella, Charlene J. Miller, Avie Ha, Casey Kim, Violeta J. Rodriguez, Margaret Fischl, Adam D. Burgener, Kelly B. Arnold, Maria L. Alcaide & Nichole R. Klatt. (2020) Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism. PLOS Pathogens 16:12, pages e1009024.
Crossref
Priyankar Dey. (2020) The pharmaco-toxicological conundrum of oleander: Potential role of gut microbiome. Biomedicine & Pharmacotherapy 129, pages 110422.
Crossref
Radislav Nakov & Tsvetelina Velikova. (2020) Chemical Metabolism of Xenobiotics by Gut Microbiota. Current Drug Metabolism 21:4, pages 260-269.
Crossref
Jose U. Scher, Renuka R. Nayak, Carles Ubeda, Peter J. Turnbaugh & Steven B. Abramson. (2020) Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nature Reviews Rheumatology 16:5, pages 282-292.
Crossref
Yuemei Sun, Juanhong Zhang, Anpeng Zhao, Wenbin Li, Qiangsheng Feng & Rong Wang. (2020) Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia. PLOS ONE 15:3, pages e0230197.
Crossref
Rosina Pryor, Daniel Martinez-Martinez, Leonor Quintaneiro & Filipe Cabreiro. (2020) The Role of the Microbiome in Drug Response. Annual Review of Pharmacology and Toxicology 60:1, pages 417-435.
Crossref
Stephanie L. Collins & Andrew D. Patterson. (2020) The gut microbiome: an orchestrator of xenobiotic metabolism. Acta Pharmaceutica Sinica B 10:1, pages 19-32.
Crossref
Pragya Misra & Shailza Singh. 2020. Metagenomic Systems Biology. Metagenomic Systems Biology 1 36 .
Benito Soto-Blanco. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 5 .
Chaonan Sun, Ling Chen & Zhu Shen. (2019) Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharmaceutical Journal 27:8, pages 1146-1156.
Crossref
Lingzhi Zhu, Guihua Duan, Cheng Yan & Jianxin Wang. (2019) Prediction of Microbe-Drug Associations Based on KATZ Measure. Prediction of Microbe-Drug Associations Based on KATZ Measure.
Lisa Maier. (2019) Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom. BIOspektrum 25:7, pages 707-710.
Crossref
Kerry L. Ivey, Andrew T. Chan, Jacques Izard, Aedin Cassidy, Geraint B. Rogers & Eric B. Rimm. (2019) Role of Dietary Flavonoid Compounds in Driving Patterns of Microbial Community Assembly. mBio 10:5.
Crossref
Naama Geva‐Zatorsky, Eran Elinav & Sven Pettersson. (2019) When Cultures Meet: The Landscape of “Social” Interactions between the Host and Its Indigenous Microbes. BioEssays 41:10.
Crossref
Priyankar Dey. (2019) Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacological Research 147, pages 104367.
Crossref
Anukriti Sharma, Mary M. Buschmann & Jack A. Gilbert. (2019) Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?. Clinical Pharmacology & Therapeutics 106:2, pages 317-328.
Crossref
Reese Hitchings & Libusha Kelly. (2019) Predicting and Understanding the Human Microbiome’s Impact on Pharmacology. Trends in Pharmacological Sciences 40:7, pages 495-505.
Crossref
Kundan Kumar, Gaurao V. Dhoke, Ashok K. Sharma, Shubham K. Jaiswal & Vineet K. Sharma. (2019) Mechanistic elucidation of amphetamine metabolism by tyramine oxidase from human gut microbiota using molecular dynamics simulations. Journal of Cellular Biochemistry 120:7, pages 11206-11215.
Crossref
Leah Guthrie, Sarah Wolfson & Libusha Kelly. (2019) The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. eLife 8.
Crossref
Jack A. Gilbert & Susan V. Lynch. (2019) Community ecology as a framework for human microbiome research. Nature Medicine 25:6, pages 884-889.
Crossref
Lauren J. Rajakovich & Emily P. Balskus. (2019) Metabolic functions of the human gut microbiota: the role of metalloenzymes. Natural Product Reports 36:4, pages 593-625.
Crossref
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, Timothy G. Dinan, John F. Cryan & Niall P. Hyland. (2019) Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacological Reviews 71:2, pages 198-224.
Crossref
Chara Litou, Angela Effinger, Edmund S Kostewicz, Karl J Box, Nikoletta Fotaki & Jennifer B Dressman. (2019) Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review. Journal of Pharmacy and Pharmacology 71:4, pages 643-673.
Crossref
Joseph L Dempsey, Dongfang Wang, Gunseli Siginir, Qiang Fei, Daniel Raftery, Haiwei Gu & Julia Yue Cui. (2019) Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis. Toxicological Sciences 168:1, pages 40-60.
Crossref
David Avelar Rodriguez, Rubén Peña Vélez, Erick Manuel Toro Monjaraz, Jaime Ramirez Mayans & Paul MacDaragh Ryan. (2018) The Gut Microbiota: A Clinically Impactful Factor in Patient Health and Disease. SN Comprehensive Clinical Medicine 1:3, pages 188-199.
Crossref
Kundan Kumar, Shubham K. Jaiswal, Gaurao V. Dhoke, Gopal N. Srivastava, Ashok K. Sharma & Vineet K. Sharma. (2018) Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme. Journal of Cellular Biochemistry 119:7, pages 5287-5296.
Crossref
Jian Xiao, Li Chen, Stephen Johnson, Yue Yu, Xianyang Zhang & Jun Chen. (2018) Predictive Modeling of Microbiome Data Using a Phylogeny-Regularized Generalized Linear Mixed Model. Frontiers in Microbiology 9.
Crossref
Brè A. Minnifield & Stella W. Aslibekyan. (2018) The Interplay Between the Microbiome and Cardiovascular Risk. Current Genetic Medicine Reports 6:2, pages 89-97.
Crossref
Nitzan Koppel, Jordan E Bisanz, Maria-Eirini Pandelia, Peter J Turnbaugh & Emily P Balskus. (2018) Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. eLife 7.
Crossref
Peter J. Turnbaugh. (2018) Making Millennial Medicine More Meta. mSystems 3:2.
Crossref
Christopher J. Moran, Hailiang Huang, Manuel Rivas, Jess L. Kaplan, Mark J. Daly & Harland S. Winter. (2018) Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLOS ONE 13:3, pages e0192806.
Crossref
Rodney R. Dietert. (2018) A Focus on Microbiome Completeness and Optimized Colonization Resistance in Neonatology. NeoReviews 19:2, pages e78-e88.
Crossref
Yoshiki Vázquez-BaezaChris Callewaert, Justine Debelius, Embriette Hyde, Clarisse Marotz, James T. MortonAustin Swafford, Alison Vrbanac, Pieter C. Dorrestein & Rob Knight. (2018) Impacts of the Human Gut Microbiome on Therapeutics. Annual Review of Pharmacology and Toxicology 58:1, pages 253-270.
Crossref
Richard Myles Turner & Sir Munir Pirmohamed. 2018. Cardiovascular Genetics and Genomics. Cardiovascular Genetics and Genomics 119 172 .
Christopher Whidbey & Aaron T. Wright. 2019. Activity-Based Protein Profiling. Activity-Based Protein Profiling 1 21 .
Paul M. Ryan, Catherine Stanton & Noel M. Caplice. (2017) Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions. Diabetology & Metabolic Syndrome 9:1.
Crossref
Michael Shaffer, Abigail J.S. Armstrong, Vanessa V. Phelan, Nichole Reisdorph & Catherine A. Lozupone. (2017) Microbiome and metabolome data integration provides insight into health and disease. Translational Research 189, pages 51-64.
Crossref
Vincent J Maffei, Sangkyu Kim, Eugene BlanchardIVIV, Meng Luo, S Michal Jazwinski, Christopher M Taylor & David A Welsh. (2017) Biological Aging and the Human Gut Microbiota. The Journals of Gerontology: Series A 72:11, pages 1474-1482.
Crossref
Ashok K. Sharma, Shubham K. Jaiswal, Nikhil Chaudhary & Vineet K. Sharma. (2017) A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Scientific Reports 7:1.
Crossref
Ines Thiele, Catherine M. Clancy, Almut Heinken & Ronan M.T. Fleming. (2017) Quantitative systems pharmacology and the personalized drug–microbiota–diet axis. Current Opinion in Systems Biology 4, pages 43-52.
Crossref
Zidong Donna Fu & Julia Yue Cui. (2017) Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites. Current Pharmacology Reports 3:3, pages 101-113.
Crossref
Rodney R. Dietert. (2017) The microbiome-immune-host defense barrier complex (microimmunosome) and developmental programming of noncommunicable diseases. Reproductive Toxicology 68, pages 49-58.
Crossref
Joël Doré, Marie-Christine Multon, Jehan-Michel Béhier, Hervé Affagard, Antoine Andremont, Philippe Barthélémy, Rui Batista, Marc Bonneville, Christophe Bonny, Gwendoline Boyaval, Mathias Chamaillard, Marie-Pierre Chevalier, Magali Cordaillat-Simmons, Fabienne Cournarie, Isabelle Diaz, Elisabeth Guillaume, Cyril Guyard, Evelyne Jouvin-Marche, François-Pierre Martin & David Petiteau. (2017) Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?. Therapies 72:1, pages 1-19.
Crossref
Joël Doré, Marie-Christine Multon, Jehan-Michel Béhier, Hervé Affagard, Antoine Andremont, Philippe Barthélémy, Rui Batitsa, Marc Bonneville, Christophe Bonny, Gwendoline Boyaval, Mathias Chamaillard, Marie-Pierre Chevalier, Magali Cordaillat-Simmons, Fabienne Cournarie, Isabelle Diaz, Elisabeth Guillaume, Cyril Guyard, Evelyne Jouvin-Marche, François-Pierre Martin & David Petiteau. (2017) The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?. Therapies 72:1, pages 21-38.
Crossref
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
E. Melancon, S. Gomez De La Torre Canny, S. Sichel, M. Kelly, T.J. Wiles, J.F. Rawls, J.S. Eisen & K. Guillemin. 2017. The Zebrafish - Disease Models and Chemical Screens. The Zebrafish - Disease Models and Chemical Screens 61 100 .
Robert G. Nichols, Nicole E. Hume, Philip B. Smith, Jeffrey M. Peters & Andrew D. Patterson. (2016) Omics Approaches To Probe Microbiota and Drug Metabolism Interactions. Chemical Research in Toxicology 29:12, pages 1987-1997.
Crossref
Matthew A. Jackson, Ian B. Jeffery, Michelle Beaumont, Jordana T. Bell, Andrew G. Clark, Ruth E. Ley, Paul W. O’Toole, Tim D. Spector & Claire J. Steves. (2016) Signatures of early frailty in the gut microbiota. Genome Medicine 8:1.
Crossref
Renuka R. Nayak & Peter J. Turnbaugh. (2016) Mirror, mirror on the wall: which microbiomes will help heal them all?. BMC Medicine 14:1.
Crossref
Kevin D. Kohl & M. Denise Dearing. (2016) The Woodrat Gut Microbiota as an Experimental System for Understanding Microbial Metabolism of Dietary Toxins. Frontiers in Microbiology 7.
Crossref
A. Braundmeier-Fleming, Nathan T. Russell, Wenbin Yang, Megan Y. Nas, Ryan E. Yaggie, Matthew Berry, Laurie Bachrach, Sarah C. Flury, Darlene S. Marko, Colleen B. Bushell, Michael E. Welge, Bryan A. White, Anthony J. Schaeffer & David J. Klumpp. (2016) Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Scientific Reports 6:1.
Crossref
Peter Spanogiannopoulos, Elizabeth N. Bess, Rachel N. Carmody & Peter J. Turnbaugh. (2016) The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nature Reviews Microbiology 14:5, pages 273-287.
Crossref
Patricia Ojeda, Alexandria Bobe, Kyle Dolan, Vanessa Leone & Kristina Martinez. (2016) Nutritional modulation of gut microbiota — the impact on metabolic disease pathophysiology. The Journal of Nutritional Biochemistry 28, pages 191-200.
Crossref
Xue Liang, Kyle Bittinger, Xuanwen Li, Darrell R Abernethy, Frederic D Bushman & Garret A FitzGerald. (2015) Bidirectional interactions between indomethacin and the murine intestinal microbiota. eLife 4.
Crossref
Michael Reck, Jürgen Tomasch, Zhiluo Deng, Michael Jarek, Peter Husemann & Irene Wagner-Döbler. (2015) Stool metatranscriptomics: A technical guideline for mRNA stabilisation and isolation. BMC Genomics 16:1.
Crossref
Kun Lu, Ridwan Mahbub & James G. Fox. (2015) Xenobiotics: Interaction with the Intestinal Microflora. ILAR Journal 56:2, pages 218-227.
Crossref
R Kaddurah‐Daouk & R Weinshilboum. (2015) Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine. Clinical Pharmacology & Therapeutics 98:1, pages 71-75.
Crossref
Johannes Espolin Roksund Hov & Marius Trøseid. (2015) Persontilpasset tarmfloramedisin?. Tidsskrift for Den norske legeforening 135:7, pages 624-624.
Crossref
Andrew D. Patterson & Peter J. Turnbaugh. (2014) Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology. Cell Metabolism 20:5, pages 761-768.
Crossref
Rachel N. Carmody & Peter J. Turnbaugh. (2014) Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. Journal of Clinical Investigation 124:10, pages 4173-4181.
Crossref
M.C. Cénit, V. Matzaraki, E.F. Tigchelaar & A. Zhernakova. (2014) Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:10, pages 1981-1992.
Crossref